Evaluation of Efficacy and Safety of Ceylon cinnamon in healthy adults
Phase 1
Completed
- Conditions
- Pharmacodynamic study
- Registration Number
- SLCTR/2013/001
- Lead Sponsor
- niversity of Colombo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Healthy human volunteers between 18 – 60 years of age
Exclusion Criteria
1. Alcohol consumption >20 g/day
2. Diagnosed Alcoholic Liver Disease (ALD),
3. Cirrhosis
4. Abnormal baseline liver, renal function tests or other haematological parameters.
5. Any chronic illness.
6. Any long term medication including any nutritional supplements.
7. Lactation, pregnancy or unwillingness to use an effective form of birth control for women of child bearing years
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of Cinnamomum zeylanicum's pharmacodynamic effects in healthy adults?
How does Ceylon cinnamon compare to other cinnamon species in metabolic and anti-inflammatory efficacy?
What biomarkers correlate with Ceylon cinnamon's pharmacokinetic and pharmacodynamic profiles in humans?
Are there documented adverse events associated with high-dose Cinnamomum zeylanicum supplementation?
What drug classes or compounds synergize with Ceylon cinnamon for metabolic syndrome management?